Article • Dean Baker’s Beat the Press
Fact-based, data-driven research and analysis to advance democratic debate on vital issues shaping people’s lives.
Center for Economic and Policy Research
1611 Connecticut Ave. NW
Suite 400
Washington, DC 20009
Tel: 202-293-5380
Fax: 202-588-1356
https://cepr.net
This vocabulary problem is apparent in a lengthy (and interesting) piece on efforts by drug companies to push opioids in large part by denying their addictiveness. These companies would have had far less incentive to lie about the dangers of opiods if they were selling at generic prices from the day they were approved by the Food and Drug Administration.
The incentive to mislead clinicians and the public about the safety and effectiveness of drugs is one of the main problems of using patent monopolies as a way to finance research. It would be good if reporters were allowed to talk about this fact.